Skip to content
Biotron Limited
  • Home
  • About Us
    • Board of Directors
    • Management Team
  • Technology
    • Clinical programs
    • Non-clinical programs
    • Intellectual property
  • News/Resources
    • Newsletters
    • In the news
    • Scientific Presentations
    • Scientific Publications
  • Investor Centre
    • ASX Announcements
    • Financial Reports
      • Annual
      • Half-year
      • Quarterly
    • Corporate Directory
    • Shareholder services
    • Options Exercise Instructions
    • Top 40 Shareholders
    • Corporate Governance
    • Corporate Presentations
  • Contacts

2020

Report on Activities for the Quarter ended 30 June 2020

29 July 2020 by Audrey Thomson

Report on Activities for the Quarter ended 30 June 2020

Categories 2020, ASX Announcements

Quarterly Report 30 June 2020

29 July 2020 by Audrey Thomson

Quarterly Report 30 June 2020

Categories 2020, ASX Announcements, Quarterly Reports

Shareholder Update

22 July 2020 by Audrey Thomson

Shareholder Update

Categories 2020, ASX Announcements

Appointment of Chief Medical Officer

17 July 2020 by Audrey Thomson

Appointment of Chief Medical Officer

Categories 2020, ASX Announcements

BIT225 Reverses HIV-Induced Immune Evasion

6 July 2020 by Audrey Thomson

BIT225 Reverses HIV Induced Immune Evasion

Categories 2020, ASX Announcements

Biotron to Present Latest BIT225 Data at International AIDS Conference

22 June 2020 by Audrey Thomson

Biotron to Present Latest BIT225 Data at International AIDS Conference

Categories 2020, ASX Announcements

Report on Activities for the Quarter ended 31 March 2020

23 April 2020 by Audrey Thomson

Report on Activities for the Quarter ended 31 March 2020

Categories 2020, ASX Announcements

Quarterly Report 31 March 2020

29 July 202023 April 2020 by Audrey Thomson

Quarterly Report 31 March 2020

Categories 2020, ASX Announcements, Quarterly Reports

R&D Tax Incentive

19 March 2020 by Audrey Thomson

R&D Tax Incentive

Categories 2020, ASX Announcements

BIT225 Restores Immune Function in HIV-1 Infections

12 March 202012 March 2020 by Audrey Thomson

BIT225 Restores Immune Function in HIV-1 Infections

Categories 2020, ASX Announcements
Post navigation
Older posts
Newer posts
← Previous Page1 Page2 Page3 Next →
© Biotron Limited 2016       ABN 60 086 399 144        Site updated 28 July 2022        Legal Notices and Privacy